⌘K

Login Start Free

Home/Filings/4/0001415889-24-022326

4//SEC Filing

Wilms Joris 4

Accession 0001415889-24-022326

CIK 0001722964other

View on SEC.gov Company Profile

Filed

Aug 26, 8:00 PM ET

Accepted

Aug 27, 5:05 PM ET

Size

4.6 KB

Accession

0001415889-24-022326

Insider Transaction Report

Form 4

Period: 2024-08-26

Y-mAbs Therapeutics, Inc.YMAB

SVP & CHIEF OPERATING OFFICER

Transactions

Sale
Common Stock
2024-08-26$14.69/sh−5,000$73,450→ 30,600 total

Documents

1 file

4
form4-08272024_090848.xmlPrimary

Issuer

Y-mAbs Therapeutics, Inc.

CIK 0001722964

Entity typeother

Related Parties

1

filerCIK 0001753231

Filing Metadata

Form type: 4
Filed: Aug 26, 8:00 PM ET
Accepted: Aug 27, 5:05 PM ET
Size: 4.6 KB

View on SEC.gov